It has further been shown that cyclin D1 overexpression can affect tamoxifen response in breast cancer cell lines (Hui et al, 2002), but contradictory results have nevertheless been published regarding this potentially important feature for cyclin D1 (Pacilio et al, 1998; Bindels et al, 2002). Here, CCND1 is linked to breast carcinoma.